Mabala, Cristina C.
HRN: 22-59-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/11/2023
CEFUROXIME 1.5GM (VIAL)
10/11/2023
10/11/2023
IV
1.5 Grams
Q8
For Stat CS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes